Main infections after engraftment
| Infections . | No. (%) of patients . |
|---|---|
| Viral infections | |
| CMV reactivation | 23 (82) |
| CMV disease | 0 (0) |
| Herpes zoster | 5 (18) |
| EBV reactivation | 5 (18) |
| PTLD | 2 (7) |
| Parvovirus | 1 (4) |
| Fungal infections | |
| Lung–Aspergillosis | 1 (4) |
| Fungemia–Candida | 2 (7) |
| Bacterial infections | |
| Gram-positive infections | 3 (22) |
| Gram-negative infections | 12 (43) |
| Infections . | No. (%) of patients . |
|---|---|
| Viral infections | |
| CMV reactivation | 23 (82) |
| CMV disease | 0 (0) |
| Herpes zoster | 5 (18) |
| EBV reactivation | 5 (18) |
| PTLD | 2 (7) |
| Parvovirus | 1 (4) |
| Fungal infections | |
| Lung–Aspergillosis | 1 (4) |
| Fungemia–Candida | 2 (7) |
| Bacterial infections | |
| Gram-positive infections | 3 (22) |
| Gram-negative infections | 12 (43) |
CMV indicates cytomegalovirus; EBV, Epstein-Barr virus; and PTLD, posttransplant lymphoproliferative disorder.